Skip to main content

IHI research and innovation agenda gets green light

The IHI Governing Board has formally approved the Strategic Research and Innovation Agenda (SRIA), which will guide IHI’s scientific priorities in the years to come.

25 January 2022
A health worker giving a thumbs up sign. Image by Syda Productions via Shutterstock

The legislation creating IHI sets out the organisation’s top-level objectives. But how do we turn these ambitious goals into real-life projects working on specific, real-life challenges in health? The answer lies in the Strategic Research and Innovation Agenda (SRIA), which has just been formally approved by the IHI Governing Board.

The document zooms in on IHI’s objectives, suggesting how IHI could address the challenges, the outputs of potential projects and their medium to long-term impacts.

The SRIA was written jointly by the European Commission and the IHI industry partners (COCIR, EFPIA, EuropaBio, MedTech Europe and Vaccines Europe). It draws heavily on a consultation on an early draft that attracted 100 responses from stakeholders including academic institutions, healthcare professionals and patients.

‘The SRIA is a vital document that will guide us as we design our calls for proposals. Thanks to the final draft of the SRIA, we’ve already come up with some plans for our first calls for proposals, so watch this space!’

- IHI Executive Director Dr Pierre Meulien

The SRIA is a living document. It will be updated, with the support of the Science and Innovation Panel and the States Representatives Group, throughout the duration of Horizon Europe to take into account future developments in health research.